Wells Fargo’s Eterna Therapeutics ERNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Hold |
0
| – | -$67 | – | 7059 |
|
|
2024
Q1 | – | Hold |
0
| – | – | – | 6754 |
|
|
2023
Q4 | – | Hold |
0
| – | – | – | 6931 |
|
|
2023
Q3 | – | Hold |
0
| – | – | – | 6889 |
|
|
2023
Q2 | – | Hold |
0
| – | – | – | 6940 |
|
|
2023
Q1 | – | Hold |
0
| – | – | – | 7092 |
|
|
2022
Q4 | – | Hold |
0
| – | – | – | 6839 |
|
|
2022
Q3 | – | Hold |
0
| – | – | – | 6828 |
|
|
2022
Q2 | – | Sell |
-7
| Closed | -$50.2K | – | 6974 |
|
|
2022
Q1 | $101K | Sell |
7
-1
| -13% | -$19K | ﹤0.01% | 5325 |
|
|
2021
Q4 | $238K | Buy |
8
+4
| +100% | +$218K | ﹤0.01% | 5172 |
|
|
2021
Q3 | $261K | Buy |
+4
| New | +$345K | ﹤0.01% | 4990 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6394 |
|
|
2021
Q1 | – | Hold |
0
| – | – | – | 6985 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 6598 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 6458 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 6402 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 6337 |
|
|
2019
Q4 | – | Hold |
0
| – | – | – | 6439 |
|
|
2019
Q3 | – | Hold |
0
| – | – | – | 6451 |
|
|
2019
Q2 | – | Hold |
0
| – | – | – | 6409 |
|
|
2019
Q1 | – | Hold |
0
| – | – | – | 6146 |
|
|
2018
Q4 | – | Hold |
0
| – | – | – | 6449 |
|
|
2018
Q3 | – | Hold |
0
| – | – | – | 6439 |
|
|
2018
Q2 | – | Hold |
0
| – | – | – | 6380 |
|
|
2018
Q1 | – | Hold |
0
| – | – | – | 6422 |
|
|
2017
Q4 | – | Hold |
0
| – | – | – | 6392 |
|
|
2017
Q3 | – | Hold |
0
| – | – | – | 6344 |
|
|
2017
Q2 | – | Hold |
0
| – | – | – | 6275 |
|
|
2017
Q1 | – | Hold |
0
| – | – | – | 6351 |
|
|
2016
Q4 | – | Hold |
0
| – | – | – | 6306 |
|
|
2016
Q3 | – | Hold |
0
| – | – | – | 6212 |
|
|
2016
Q2 | – | Hold |
0
| – | – | – | 6153 |
|
|
2016
Q1 | – | Hold |
0
| – | – | – | 6257 |
|
|
2015
Q4 | – | Hold |
0
| – | – | – | 6269 |
|
|
2015
Q3 | – | Hold |
0
| – | – | – | 6259 |
|
|
2015
Q2 | – | Hold |
0
| – | – | – | 6388 |
|
|
2015
Q1 | – | Hold |
0
| – | – | – | 6217 |
|
|
2014
Q4 | – | Hold |
0
| – | – | – | 6258 |
|
|
2014
Q3 | – | Hold |
0
| – | – | – | 6211 |
|
|
2014
Q2 | – | Hold |
0
| – | – | – | 6149 |
|
|
2014
Q1 | – | Hold |
0
| – | – | – | 5923 |
|
|
2013
Q4 | – | Hold |
0
| – | – | – | 5778 |
|
|
2013
Q3 | – | Hold |
0
| – | – | – | 5692 |
|
|
2013
Q2 | – | Hold |
0
| – | – | – | 5603 |
|
Other funds holding ERNA
CPWM
NW
SCA
AWE
BWP
TRCT
Wells Fargo's ERNA Position: Q2 2024 in Review
Wells Fargo held its Eterna Therapeutics (ERNA) position steady in Q2 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #7059.
Wells Fargo first reported a position in ERNA in Q3 2021 and has held it in 3 quarters since. The position peaked at $261K in Q3 2021. 11 funds tracked by Wall St. Rank hold ERNA as of Q2 2024.
- Wells Fargo held 0 shares of Eterna Therapeutics worth $0 as of Q2 2024.
- Wells Fargo left its Eterna Therapeutics share count unchanged in Q2 2024.
- Eterna Therapeutics made up ﹤0.01% of Wells Fargo's portfolio in Q2 2024, its #7059 holding.
- Wells Fargo first reported a position in Eterna Therapeutics in Q3 2021 and has held it in 3 quarters since.
- Wells Fargo's Eterna Therapeutics position peaked at $261K in Q3 2021.
- 11 funds tracked by Wall St. Rank held Eterna Therapeutics as of Q2 2024.
Based on Wells Fargo's 13F filing for Q2 2024, filed 13 Aug 2024.